Henry Schein (HSIC)
NASDAQHealth CareMedical - DistributionSnapshot 2026-09-04
$89.81-1.16%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DistributionSnapshot 2026-09-04
QuarterlyIQ Insights · HSIC
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $90 HSIC trades at 17× p/e, below its 23× p/e peer median. Our $96 fair value sits above the price. It's a high-confidence read. Analysts target $85–$110. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $97.50 | — | — | Analyst | high |
| dcf fcfe | 12M | $154.49 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $101.74 | — | — | Hist. CAGR | high |
| graham number | 12M | $63.14 | — | — | TTM | high |
| Peer EV/EBITDA |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$85.00 – $110.00 (median $97.50) · 8 analysts · as of 2026-08-19
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| 12M |
| $74.22 |
| 12.7 |
| 8.19 |
| TTM |
| high |
| Peer P/FCF | 12M | $100.55 | 21.3 | 4.71 | TTM | high |
| Peer P/E | 12M | $109.01 | 18.7 | 5.82 | ntm analyst | high |
| Peer P/S | 12M | $451.60 | 3.8 | 118.91 | TTM | high |
| PEG | 12M | $118.67 | 22.3 | 5.31 | TTM | high |
| residual income | 12M | $44.07 | — | — | TTM | high |
| Own P/E history | 12M | $89.08 | 16.8 | 5.31 | TTM | high |
| triangulated | 12M | $126.46 | 22.9 | 5.52 | Triangulated | high |
| Peer P/FCF | 3Y | $104.02 | 21.3 | 4.87 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $121.70 | 18.7 | 6.49 | Analyst | medium |
| Peer P/S | 3Y | $517.47 | 3.8 | 136.25 | guidance | medium |
| PEG | 3Y | $145.10 | 22.3 | 6.49 | Analyst | medium |
| Own P/E history | 3Y | $108.91 | 16.8 | 6.49 | Analyst | medium |
| Peer P/FCF | 5Y | $106.41 | 21.3 | 4.99 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $132.90 | 18.7 | 7.09 | Analyst | high |
| Peer P/S | 5Y | $565.09 | 3.8 | 148.79 | guidance | high |
| PEG | 5Y | $158.45 | 22.3 | 7.09 | Analyst | high |
| Own P/E history | 5Y | $118.94 | 16.8 | 7.09 | Analyst | high |